4K views · 92 reactions | Monoclonal antibody treatment is for people who have COVID-19 and are not hospitalized or who have recently been exposed. This treatment can help your body fight COVID-19 while your immune system begins to make its own antibodies. Learn more about monoclonal antibody treatment: https://on.nyc.gov/antibody-treatment Find a monoclonal antibody treatment facility near you: https://on.nyc.gov/3jlxY1j | NYC Department of Health and Mental Hygiene | Facebook

17K views · 148 reactions | Doctors say a treatment involving monoclonal antibodies is a potential lifesaver for COVID patients in the early stages of infection. But they caution it's still no substitute for getting vaccinated. "There's no question a vaccine is better than an antibody." — Dr. David Agus | CBS Mornings | Facebook

Today NIH announced the launch of #ACTIV-2 (outpatient) Phase 2/3 and ACTIV-3 (inpatient) Phase 3 clinical trials investigating the use of monoclonal antibodies as a potential treatment for #COVID19. Antibodies are molecules our immune systems use to fight germs. People recovered from #COVID19 can produce antibodies. Researchers can examine blood samples from COVID-19 survivors & isolate antibodies. Scientists then create lab-engineered copies, thus making monoclonal antibodies. | National Insti

14K views · 280 reactions | Neutralizing monoclonal antibodies (mAbs) may be a highly effective way to treat and prevent COVID-19 while awaiting a vaccine. This video explains how these drugs are created and how they target the SARS-CoV-2 virus. National Institutes of Health (NIH) & UNC Institute for Global Health and Infectious Diseases | JAMA | Facebook

145K views | Reel by All About Molecular Biology